Loading...
•
Dec 31, 2025
AdaptHealth Q4 2025 Earnings Report
AdaptHealth reported fourth quarter 2025 net loss attributable to AdaptHealth Corp. of 102770000 on net revenue of 846289000.
Key Takeaways
AdaptHealth generated Q4 2025 net revenue of 846289000 with organic revenue growth of 1.7%, while reporting a net loss attributable to AdaptHealth Corp. of 102770000, impacted by a 127995000 goodwill impairment charge. Adjusted EBITDA was 163143000 with a 19.3% margin.
Net revenue was 846289000, down 1.2% year over year.
Organic revenue growth was 1.7% in the quarter.
Net loss attributable to AdaptHealth Corp. was 102770000 due to goodwill impairment.
Adjusted EBITDA was 163143000 with a 19.3% margin.
Forward Guidance
For fiscal year 2026, AdaptHealth expects net revenue between 3440000000 and 3510000000, Adjusted EBITDA between 680000000 and 730000000, and free cash flow between 175000000 and 225000000.
Positive Outlook
- 2026 net revenue guidance of 3440000000 to 3510000000.
- 2026 Adjusted EBITDA guidance of 680000000 to 730000000.
- 2026 free cash flow guidance of 175000000 to 225000000.
- Underlying earnings power supported by new capitated contract.
- Continued investment in digital engagement and infrastructure.
Challenges Ahead
- Goodwill impairment significantly impacted GAAP earnings.
- Adjusted EBITDA declined year over year in Q4.
- Revenue decreased 1.2% year over year in Q4.
- Higher operating costs including legal settlement expense.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...